Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 38-46 , March 2007

Radiofrequency Ablation of Liver Cancer

  • Riccardo Lencioni, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to. Prof. Riccardo Lencioni, Division of Diagnostic and Interventional Radiology, University of Pisa, Via Roma 67, I-56125 Pisa, Italy.
    • ,
  • Laura Crocetti, MD, PhD

References 

  1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  2. Sherman M. Hepatocellular carcinoma: Epidemiology, risk factors, and screening. Semin Liver Dis. 2005;25:143–154
  3. Bruix J, Boix L, Sala M, et al. Focus on hepatocellular carcinoma. Cancer Cell. 2004;5:215–219
  4. Bruix J, Sherman M, Llovet JM, et al. EASL Panel of Experts on HCC Clinical management of hepatocellular carcinoma (Conclusions of the Barcelona-2000 EASL conference European Association for the Study of the Liver). J Hepatol. 2001;35:421–430
  5. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  6. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation. Hepatology. 1999;30:1434–1440
  7. Bentrem DJ, Dematteo RP, Blumgart LH. Surgical therapy for metastatic disease to the liver. Annu Rev Med. 2005;56:139–156
  8. Weitz J, Blumgart LH, Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg. 2005;241:269–276
  9. Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases (Technique, indications, results, and new promises). Invest Radiol. 2004;39:689–697
  10. Lencioni R, Cioni D, Crocetti L, et al. Percutaneous ablation of hepatocellular carcinoma: State-of-the-art. Liver Transpl. 2004;10:S91–S97
  11. Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis. 2005;9:301–314
  12. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol. 2004;14:2261–2267
  13. Lencioni R, Crocetti L, Cioni R, et al. Radiofrequency ablation of lung malignancies: Where do we stand?. Cardiovasc Intervent Radiol. 2004;27:581–590
  14. Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: A prospective study. J Clin Oncol. 2005;23:1358–1364
  15. Rhim H, Dodd GD, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: Lessons learned from complications. Radiographics. 2004;24:41–45
  16. Chopra S, Dodd GD, Chanin MP, et al. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: Feasibility and safety. AJR Am J Roentgenol. 2003;180:697–701
  17. Rhim H, Goldberg SN, Dodd GD, et al. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21:S17–S35
  18. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancies: A unified approach to underlyng principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174:323–331
  19. Dodd GD, Frank MS, Aribandi M, et al. Radiofrequency thermal ablation: Computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol. 2001;177:777–782
  20. Pennes HH. Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol. 1948;1:93–122
  21. Goldberg SN, Charboneau JW, Dodd GD, et al. International Working Group on Image-Guided Tumor Ablation Image-guided tumor ablation: Proposal for standardization of terms and reporting criteria. Radiology. 2003;228:335–345
  22. Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119–126
  23. Goldberg SN, Saldinger PF, Gazelle GS, et al. Percutaneous tumor ablation: Increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Radiology. 2001;220:420–427
  24. Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: Results of a pilot clinical trial. Eur Radiol. 1998;8:1205–1211
  25. Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic malignancies: Results in 123 patients. Ann Surg. 1999;230:1–8
  26. Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: Indications, limitations, and complications. Ann Surg Oncol. 2000;7:593–600
  27. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: Treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234:954–960
  28. Lencioni R, Allgaier HP, Cioni D, et al. Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology. 2003;228:235–240
  29. Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology. 2004;127:1714–1723
  30. Shiina S, Teratani T, Obi S, et al. A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology. 2005;129:122–130
  31. Lencioni R, Cioni D, Crocetti L, et al. Early-stage hepatocellular carcinoma in cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation. Radiology. 2005;234:961–967
  32. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer. 2005;103:1201–1209
  33. Cabassa P, Donato F, Simeone F, et al. Radiofrequency ablation of hepatocellular carcinoma: Long-term experience with expandable needle electrodes. AJR Am J Roentgenol. 2006;185:S316–S321
  34. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: Long-term results and prognostic factors in a large single-institution series. Eur Radiol. 2007;17:684–692
  35. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243:321–328
  36. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology. 1997;205:367–373
  37. De Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol. 2000;175:1619–1625
  38. Helmberger T, Holzknecht N, Schopf U, et al. Radiofrequency ablation of liver metastases (Technique and initial results). Radiologe. 2001;41:69–76
  39. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: Long-term results in 117 patients. Radiology. 2001;221:159–166
  40. Jackobs TF, Hoffmann RT, Trumm C, et al. Radiofrequency ablation of colorectal liver metastases: Mid-term results in 68 patients. Anticancer Res. 2006;26:671–680
  41. Sorensen SM, Mortensen FV, Nielsen DT. Radiofrequency ablation of colorectal liver metastases: Long-term survival. Acta Radiol. 2007;48:253–258
  42. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–825
  43. Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003;90:1240–1243
  44. Elias D, De Baere T, Smayra T, et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg. 2002;89:752–756
  45. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The “test-of-time approach”. Cancer. 2003;97:3027–3035
  46. Rhim H. Complications of radiofrequency ablation in hepatocellular carcinoma. Abdom Imaging. 2005;30:409–418
  47. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: Complications encountered in a multicenter study. Radiology. 2003;26:441–451
  48. De Baere T, Risse O, Kuoch V, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003;181:695–700
  49. Bleicher RJ, Allegra DP, Nora DT, et al. Radiofrequency ablation in 447 complex unresectable liver tumors: Lessons learned. Ann Surg Oncol. 2003;10:52–58
  50. Llovet JM, Vilana R, Bru C, et al. Barcelona Clinic Liver Cancer (BCLC) Group Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology. 2001;33:1124–1129
  51. Lencioni R, Della Pina C, Crocetti L, et al. Percutaneous ablation of hepatocellular carcinoma. Recent Results Cancer Res. 2006;167:91–105

PII: S1089-2516(07)00072-8

doi: 10.1053/j.tvir.2007.08.006

Techniques in Vascular & Interventional Radiology
Volume 10, Issue 1 , Pages 38-46 , March 2007

Article Tools

* Image Usage & Resolution